Evidence map›Paper›PMID 31072069›Full record

ArticleMolecules (Basel, Switzerland)2019

Robustaflavone Isolated from

Ara Jo, Hyun Ji Yoo, Mina Lee

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. AnHeliyon · 2024
    Article
  6. Frontiers in pharmacology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Anti-Inflammatory Effects ofBioMed research international · 2022
    Article
  11. Article
  12. A Purified Biflavonoid Extract FromFrontiers in pharmacology · 2021
    Article
  13. Article
  14. Sudachinoid- and Ichangensin-Type Limonoids fromInternational journal of molecular sciences · 2020
    Article
  15. New robustaflavone fromJournal of advanced pharmaceutical technology & research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ara JoCollege of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si 57922, Jeonnam, Korea. coo123mm@naver.com.
Hyun Ji YooCollege of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si 57922, Jeonnam, Korea. youhj915@naver.com.
Mina LeeCollege of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon-si 57922, Jeonnam, Korea. minalee@sunchon.ac.kr.
Sunchon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Down-RegulationAnimalsBerberidaceaeBiflavonoidsCell DeathCell SurvivalChemical FractionationCyclooxygenase 2EnterocytesExtracellular Signal-Regulated MAP KinasesHT29 CellsHumansInflammation MediatorsInterleukin-1betaInterleukin-6Interleukin-8BiflavonoidsCyclooxygenase 2Extracellular Signal-Regulated MAP KinasesInflammation MediatorsInterleukin-1betaInterleukin-6Interleukin-8LipopolysaccharidesNF-kappa BNitric OxideNitric Oxide Synthase Type IIPhytochemicalsPlant Extractsrobustaflavonebioactivity-guided isolationinflammatory bowel diseaseinflammatory mediatorsNandina domesticarobustaflavone

Identifiers

PMID31072069
PMCPMC6540067
OpenAlexW2944202421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.